tiprankstipranks
Trending News
More News >
Protagenic Therapeutics (PTIX)
NASDAQ:PTIX
US Market

Protagenic Therapeutics (PTIX) Financial Statements

Compare
70 Followers

Protagenic Therapeutics Financial Overview

Protagenic Therapeutics's market cap is currently $3.07M. The company's EPS TTM is $-15.832; its P/E ratio is ―; Protagenic Therapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ -28.22K$ 0.00$ 0.00$ -286.00
Operating Income$ -5.70M$ -4.53M$ -3.56M$ -4.14M$ -2.55M
EBITDA$ -5.47M$ -4.50M$ -3.37M$ -4.14M$ -2.55M
Net Income$ -5.53M$ -5.00M$ -3.56M$ -4.52M$ -2.79M
Balance Sheet
Cash & Short-Term Investments$ 1.84M$ 4.06M$ 7.98M$ 10.37M$ 671.09K
Total Assets$ 1.96M$ 4.32M$ 8.04M$ 11.06M$ 879.25K
Total Debt$ 0.00$ 0.00$ 344.23K$ 318.43K$ 1.37M
Net Debt$ -1.84M$ -1.29M$ 129.04K$ -222.74K$ 702.71K
Total Liabilities$ 942.76K$ 655.25K$ 1.12M$ 1.12M$ 2.03M
Stockholders' Equity$ 1.01M$ 3.67M$ 6.92M$ 9.94M$ -1.15M
Cash Flow
Free Cash Flow$ -4.22M$ -3.85M$ -2.00M$ -2.80M$ -1.35M
Operating Cash Flow$ -4.22M$ -3.70M$ -1.99M$ -2.80M$ -1.35M
Investing Cash Flow$ 2.80M$ 4.78M$ 1.60M$ -9.91M$ 0.00
Financing Cash Flow$ 1.96M$ 0.00$ 0.00$ 12.58M$ 1.22M
Currency in USD

Protagenic Therapeutics Earnings and Revenue History

Protagenic Therapeutics Debt to Assets

Protagenic Therapeutics Cash Flow

Protagenic Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis